CLOs on the Move

Apollo Endosurgery

www.apolloendo.com

 
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo`s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo`s products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the X-Tack™ Endoscopic HeliX Tacking System, and the ORBERA® Intragastric Balloon.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.apolloendo.com
  • 1120 South Capital of Texas Highway Building 1, Suite 300
    Austin, TX USA 78746
  • Phone: 512.279.5100

Executives

Name Title Contact Details
David Hooper
Vice President- Quality and Regulatory Affairs Profile
Brian Szymczak
Vice President, Legal and Compliance Profile

Similar Companies

Advanced Tissue

Advanced Tissue is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reprieve Cardiovascular

Reprieve Cardiovascular is led by a seasoned management team with extensive experience in the medical device industry.

Implanet

Founded in 2007 and based near Bordeaux, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.

Sedecal USA

Sedecal USA is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.